Gene Mediated Anti-Cancer Strategies Involving the Vasculature
Inhibition of Angiogenesis and Vascular Targeting of Gene Therapy
Part of the NATO ASI Series book series (NSSA, volume 294)
Recently, novel approaches to anti-cancer therapy have been described that involve gene transfer. These include anti-angiogenic strategies and vascular targeting of gene therapy.
KeywordsThymidine Phosphorylase Cytosine Deaminase Packaging Cell Line Vascular Target Viral Producer Cell
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Montgomery, K.F., Osborn L., Hession, C., Tizard, R., Goff, D., Vassallo, C., Tarr, P.I., Bomsztyk, K., Lobb, R., Harlan, J.M., and Pohlman, T.H. Activation of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA, 88:6523–6527, 1991.PubMedCrossRefGoogle Scholar
- Patterson, A.V., Zhang, H-T., Moghaddam, A., Bicknell, R., Talbot, D.C., Stratford, I.J., and Harris, A.L. Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br. J. Cancer, 72:669–675, 1995a.PubMedCrossRefGoogle Scholar
© Springer Science+Business Media New York 1998